25957-65-7 Usage
Description
6-Azaindole-3-carboxaldehyde is a heterocyclic chemical compound with the molecular formula C9H7NO. It features a nitrogen and oxygen atom within its ring structure, making it a versatile building block in organic synthesis.
Uses
Used in Pharmaceutical and Agrochemical Industries:
6-Azaindole-3-carboxaldehyde is used as a key intermediate in the synthesis of various pharmaceuticals and agrochemicals. Its unique structure and functional groups contribute to the development of new and effective compounds for medical and agricultural applications.
Used in Dye and Pigment Industries:
6-Azaindole-3-carboxaldehyde is utilized in the production of dyes, pigments, and other fine chemicals. Its chemical properties allow for the creation of a wide range of colorants and specialty chemicals used in various industries.
Used in Materials Science:
6-Azaindole-3-carboxaldehyde has potential applications in the field of materials science, particularly in the development of advanced polymers and functional materials. Its versatile reactivity and functional groups enable the synthesis of innovative materials with unique properties and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 25957-65-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,9,5 and 7 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 25957-65:
(7*2)+(6*5)+(5*9)+(4*5)+(3*7)+(2*6)+(1*5)=147
147 % 10 = 7
So 25957-65-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H6N2O/c11-5-7-3-6-1-2-9-4-8(6)10-7/h1-5,10H
25957-65-7Relevant articles and documents
VIRAL REPLICATION INHIBITORS
-
Page/Page column 200, (2013/04/13)
The present invention relates to a series of novel compounds, methods to prevent or treat viral infections in animals by using the novel compounds and to said novel compounds for use as a medicine, more preferably for use as a medicine to treat or prevent viral infections, particularly infections with RNA viruses, more particularly infections with viruses belonging to the family of the Flaviviridae, and yet more particularly infections with the Dengue virus. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the novel compounds, to the compositions or preparations for use as a medicine, more preferably for the prevention or treatment of viral infections. The invention also relates to processes for preparation of the compounds.
